Last reviewed · How we verify
SOR007 Ointment 0.3%
At a glance
| Generic name | SOR007 Ointment 0.3% |
|---|---|
| Sponsor | DFB Soria, LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of SOR007 Ointment for Actinic Keratosis (PHASE2)
- Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |